Search the Newsreel

RBC Adjusts Price Target on Legend Biotech to $58 From $59, Maintains Outperform Rating

RBC Capital Markets has adjusted its price target for Legend Biotech (LEGN) to $58, down from $59, while reiterating an Outperform rating on the stock. This revision comes amidst recent news for Legend Biotech, including a downgrade from Oppenheimer and the company reporting its …

We Think Crexendo's (NASDAQ:CXDO) Profit Is Only A Baseline For What They Can Achieve

Crexendo, Inc. (NASDAQ:CXDO) recently posted solid earnings, but the market appears to be overly pessimistic. Analysis shows that the company's statutory earnings are likely conservative due to a negative accrual ratio and the impact of unusual items. However, shareholder dilution from new share issuance …

The Top 5 Analyst Questions From Oaktree Specialty Lending’s Q2 Earnings Call

Extendicare Inc. Stock Faces Renewed Pressure as Investor Caution Builds

Legend Biotech Releases Q2 2026 Financial Results

Legend Biotech (LEGN) reported strong Q2 2026 financial results, with adjusted earnings of $0.16 per share, surpassing estimates. The company generated $387.5 million in revenue, largely driven by its CARVYKTI collaboration, indicating significant growth and market penetration for its cell therapy platform. Wall Street …

Legend Turns Profitable In Q2 As CARVYKTI Sales Jump By 50%

(RTTNews) - Legend Biotech Corporation (LEGN) released financial results for the second quarter ended June 30, 2026. The commercial-stage company turned profitable in the second quarter, compared with a loss in the prior-year quarter, driven by higher collaboration revenue and improved operating income. For …

Legend Biotech (LEGN) Stock Rebounds As Profit Arrives But Carvykti Risk Persists

Dimensional Fund Advisors LP Buys Shares of 2,606,620 Accendra Health, Inc. $ACH

Dimensional Fund Advisors LP recently acquired 2,606,620 shares of Accendra Health, Inc. (NYSE:ACH) during the first quarter, valuing their new stake at approximately $5.94 million. Other institutional investors also modified their holdings, while the company reported missing analyst earnings estimates for the latest quarter. …

Why Mendell Helium’s (LSE:MDH) Shareholding Update Is Drawing Attention

Legend Biotech (LEGN) Returned To Profit, Is The Stock Still Cheap?

Premier Miton Group Lowers Mendell Helium plc (MDH) Voting Rights to 14.40% After Share Disposal

JHS Svendgaard Laboratories consolidated net profit rises 2.83% in the June 2026 quarter

Accendra Health (ACHC) Stock Sinks As Losses Deepen And Cash Stays Tight

Here's How Much $100 Invested In Ascendis Pharma 5 Years Ago Would Be Worth Today

Ascendis Pharma (NASDAQ: ASND) has outperformed the market over the past five years, achieving an average annual return of 17.21%. A $100 investment in ASND five years ago would now be worth $212.53, demonstrating the power of compounded returns. The article highlights the significant …

Crexendo Inc (CXDO) (Q2 2026) Earnings Call Highlights: Revenue Surges 49% as Platform Wins ...

Crexendo reported strong Q2 2026 results with a 49% revenue increase to $24.6 million, driven by the ESI acquisition and growth in telecom services. The company achieved GAAP net income of $1.1 million and a substantial increase in new platform customers, securing 11 new …

Legend Biotech (LEGN) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Tuesday, Aug. 11, 2026 at 8:00 a.m. ET CALL PARTICIPANTS Interim Chief Executive Officer - Alan BashChief Financial Officer - Carlos SantosInterim Head of R&D - Yuhong QiuDirector of Investor Relations - Caroline LeCates Paul TAKEAWAYS Worldwide Net …

Carlyle Secured Lending Earnings Call Signals Turnaround

Crexendo (CXDO) Q2 2026 Earnings Call Transcript

Crexendo reported strong Q2 2026 results with a 49% revenue increase to $24.6 million, driven by the ESI acquisition and growth in telecom services. The company achieved GAAP net income of $1.1 million and a substantial increase in new platform customers, securing 11 new …

LendingTree Number of Employees 2026 | Employee Count & Headcount Data

As of March 2026, LendingTree, Inc. has approximately 954 employees worldwide, representing a 1.5% growth since 2023 but a 1.0% decline year-over-year. The company, headquartered in Charlotte, North Carolina, has its workforce concentrated in North America (77.3%) and is actively hiring, despite a 28.2% …

Opendoor (OPEN) Q2 2026 Earnings Call Transcript

Legend Biotech Corporation 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:LEGN) 2026-08-11

This article first appeared on GuruFocus. Total Revenue: Increased 52% year over year, driven by continued CARVYKTI demand and commercial expansion. CARVYKTI Net Trade Sales: Approximately $657 million worldwide, representing 50% year-over-year growth and 10% sequential growth. U.S. CARVYKTI Sales: Increased 32% year over …

Citi Trends Sees Q2 Comps Expand 10.5 Percent

Citi Trends reported preliminary Q2 2026 results showing a 10.5 percent increase in comparable store sales, leading to a 10.9 percent rise in total sales to $211.6 million. This marks the eighth consecutive quarter of comparable store sales growth, attributed to strategic transformation, enhanced …

Wells Fargo Maintains Carlyle Secured Lending(CGBD.US) With Buy Rating, Maintains Target Price $12

Wells Fargo has reiterated its Buy rating for Carlyle Secured Lending (CGBD.US), maintaining a target price of $12. This indicates a continued positive outlook from the firm regarding the company's stock performance.

Wendy’s Turnaround Plan, Dividend Cut, and Pulled Guidance Might Change The Case For Investing In Wendy’s (WEN)

Earlier this month, The Wendy's Company reported second-quarter 2026 results showing slightly higher revenue of US$570.57 million but sharply lower net income of US$32.62 million, withdrew its 2026 financial outlook, recorded higher asset impairments, and cut its annualized dividend to US$0.28 per share to …

(MEGI) Volatility Zones as Tactical Triggers

This article provides an AI-generated analysis of Mainstay Cbre Global Infrastructure Megatrends Term Fund (NASDAQ: MEGI), indicating neutral near and mid-term readings but a potential moderation of a long-term positive bias. It identifies an exceptional 16.5:1 risk-reward short setup and outlines specific institutional trading …

Legend Biotech Corp (LEGN) (Q2 2026) Earnings Call Highlights: First Profitable Quarter Driven ...

This article first appeared on GuruFocus. Total Revenue: Increased 52% year over year, driven by continued CARVYKTI demand and commercial expansion. CARVYKTI Net Trade Sales: Approximately $657 million worldwide, representing 50% year-over-year growth and 10% sequential growth. U.S. CARVYKTI Sales: Increased 32% year over …

Tenda (TEND3): Conversão consistente de resultados em caixa sustenta perspectivas positivas

Nevada small-business bankruptcies jump 30% as economic pressures mount, LendingTree says

Nevada has seen a significant increase in small-business bankruptcies, with a 30.4% jump over the past year, according to LendingTree. This rate is the fourth-highest in the U.S., with 103.2 filings per 100,000 small businesses. The national trend also shows an 11.4% increase in …

B. Riley Adjusts Price Target on Sixth Street Specialty Lending to $20 From $21, Maintains Buy Rating

B. Riley has adjusted its price target for Sixth Street Specialty Lending (TSLX) to $20, down from $21, while reiterating a Buy rating on the stock. This revision suggests a slight change in the firm's valuation perspective for the company. Despite the lower price …

Analysts Offer Insights on Financial Companies: Carlyle Secured Lending Inc (CGBD), Onity Group (ONIT) and Sun Life Financial (SLF)

Analysts from Wells Fargo, BTIG, and Scotiabank have provided insights into several financial companies. Carlyle Secured Lending Inc (CGBD) received a Buy rating with a $12.00 price target from Wells Fargo, and a Moderate Buy consensus from the Street. Onity Group (ONIT) was rated …

Global Dividend Growth Split Corp.’s 10.09% Yield Has Solid NAV Support, but Market Leverage Keeps Income Risk Elevated

Legend Biotech Gains 6% on Q2 Earnings Beat as Adjusted EPS Doubles Consensus

Legend Biotech (NASDAQ:LEGN) surged 6% after reporting its first-ever profitable quarter in Q2 2026, with revenue of $387.5 million beating estimates and adjusted EPS of $0.16 doubling consensus. The strong performance was driven by CARVYKTI net sales reaching $657 million, up 50% year-over-year, and …

BSP Stock Extends Breakout As Momentum Traders Pile In

Bending Spoons S.p.A. (BSP) stock has surged over 70% in recent weeks, trading up 11.11% on August 11, 2026, driven by aggressive momentum trading and highly positive growth prospects. Despite revenue of $1.31B and positive net income, BSP's valuation ratios are extremely high (P/E …

Crexendo (CXDO) is an Incredible Growth Stock: 3 Reasons Why

Crexendo (CXDO) is identified as an incredible growth stock by Zacks' proprietary system, earning a favorable Growth Score and a top Zacks Rank. The company shows strong prospects with an expected EPS growth of 25% this year, crushing the industry average, and an impressive …

Why TerrAscend Corp. stock is rising today

Bending Spoons stock continues to surge ahead of first public earnings report

Bending Spoons' stock is surging, up 84.48% YTD, driven by aggressive M&A, particularly the $1.29 billion Airtable deal, and anticipation of its first public earnings report on August 13. While analysts like Mizuho's Daniel Dolev see significant upside, potentially to $95 per share, valuation …